Hamanaka, K., Miura, K., Koyama, T., Matsuoka, S., Takeda, T., Yamada, K., & Hyogotani, A. (2019). The pretreatment circulating albumin-to-fibrinogen ratio in patients with non-small cell lung cancer: A simple, economical, and effective biomarker. J Thorac Dis.

Hamanaka, Kazutoshi, Kentaro Miura, Tsutomu Koyama, Shunichiro Matsuoka, Tetsu Takeda, Kyoko Yamada, ja Akira Hyogotani. "The Pretreatment Circulating Albumin-to-fibrinogen Ratio in Patients With Non-small Cell Lung Cancer: A Simple, Economical, and Effective Biomarker." J Thorac Dis 2019.

Hamanaka, Kazutoshi, et al. "The Pretreatment Circulating Albumin-to-fibrinogen Ratio in Patients With Non-small Cell Lung Cancer: A Simple, Economical, and Effective Biomarker." J Thorac Dis 2019.